The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics Inc | EQUITIES | 00461U105 | 5,547,040 | 352,193 | SH | SOLE | 352,193 | 0 | 0 | |||
Acumen Pharmaceuticals Inc | EQUITIES | 00509G209 | 1,593,621 | 295,115 | SH | SOLE | 295,115 | 0 | 0 | |||
Aerovate Therapeutics Inc | EQUITIES | 008064107 | 1,081,346 | 36,906 | SH | SOLE | 36,906 | 0 | 0 | |||
Akero Therapeutics Inc | LONG OPTION PUTS | 00973Y108 | 8,220,000 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | ||
Akero Therapeutics Inc | LONG OPTION CALLS | 00973Y108 | 8,220,000 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | ||
Akero Therapeutics Inc | EQUITIES | 00973Y108 | 9,431,080 | 172,100 | SH | SOLE | 172,100 | 0 | 0 | |||
Allakos Inc | EQUITIES | 01671P100 | 4,047,502 | 480,701 | SH | SOLE | 480,701 | 0 | 0 | |||
Alnylam Pharmaceuticals Inc | EQUITIES | 02043Q107 | 8,947,998 | 37,652 | SH | SOLE | 37,652 | 0 | 0 | |||
Altimmune Inc | EQUITIES | 02155H200 | 831,482 | 50,546 | SH | SOLE | 50,546 | 0 | 0 | |||
Altimmune, Inc. | LONG OPTION CALLS | 02155H200 | 2,632,000 | 160,000 | SH | Call | SOLE | 160,000 | 0 | 0 | ||
Amryt Pharma PLC | EQUITIES | 03217L106 | 1,408,864 | 192,995 | SH | SOLE | 192,995 | 0 | 0 | |||
Anavex Life Science Corp | LONG OPTION PUTS | 032797300 | 9,331,302 | 1,007,700 | SH | Put | SOLE | 1,007,700 | 0 | 0 | ||
Anavex Life Science Corp | LONG OPTION CALLS | 032797300 | 950,076 | 102,600 | SH | Call | SOLE | 102,600 | 0 | 0 | ||
Ascendis Pharma A/S | EQUITIES | 04351P101 | 2,827,432 | 23,151 | SH | SOLE | 23,151 | 0 | 0 | |||
Astria Therapeutics Inc | EQUITIES | 04635X102 | 1,209,128 | 81,204 | SH | SOLE | 81,204 | 0 | 0 | |||
Avidity Biosciences Inc | EQUITIES | 05370A108 | 2,840,320 | 128,000 | SH | SOLE | 128,000 | 0 | 0 | |||
Axsome Therapeutics Inc | EQUITIES | 05464T104 | 771,300 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
Bellus Health Inc | EQUITIES | 07987C204 | 14,034,581 | 1,707,370 | SH | SOLE | 1,707,370 | 0 | 0 | |||
BioCryst Pharmaceuticals Inc | EQUITIES | 09058V103 | 3,124,546 | 272,173 | SH | SOLE | 272,173 | 0 | 0 | |||
Bioatla Inc | EQUITIES | 09077B104 | 4,511,719 | 546,875 | SH | SOLE | 546,875 | 0 | 0 | |||
Biogen Idec Inc | EQUITIES | 09062X103 | 6,085,317 | 21,975 | SH | SOLE | 21,975 | 0 | 0 | |||
Braze Inc | EQUITIES | 10576N102 | 272,800 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
CTI BioPharma Corp | EQUITIES | 12648L601 | 1,528,710 | 254,361 | SH | SOLE | 254,361 | 0 | 0 | |||
Celldex Therapeutics Inc | EQUITIES | 15117B202 | 2,437,934 | 54,699 | SH | SOLE | 54,699 | 0 | 0 | |||
Cerus Corp | EQUITIES | 157085101 | 5,964,151 | 1,634,014 | SH | SOLE | 1,634,014 | 0 | 0 | |||
Cincor Pharma Inc | EQUITIES | 17240Y109 | 4,859,245 | 395,382 | SH | SOLE | 395,382 | 0 | 0 | |||
Codexis Inc | EQUITIES | 192005106 | 674,474 | 144,737 | SH | SOLE | 144,737 | 0 | 0 | |||
Cogent Biosciences Inc | EQUITIES | 19240Q201 | 2,069,240 | 179,000 | SH | SOLE | 179,000 | 0 | 0 | |||
Compass Therapeutics Inc. | EQUITIES | 20454B104 | 1,349,584 | 268,307 | SH | SOLE | 268,307 | 0 | 0 | |||
Compugen Ltd | EQUITIES | M25722105 | 477,689 | 667,443 | SH | SOLE | 667,443 | 0 | 0 | |||
Crinetics Pharmaceuticals Inc | EQUITIES | 22663K107 | 2,795,270 | 152,747 | SH | SOLE | 152,747 | 0 | 0 | |||
Cue Biopharma Inc | EQUITIES | 22978P106 | 872,892 | 306,278 | SH | SOLE | 306,278 | 0 | 0 | |||
Cullinan Oncology Inc | EQUITIES | 230031106 | 2,420,339 | 229,416 | SH | SOLE | 229,416 | 0 | 0 | |||
Cvrx Inc | EQUITIES | 126638105 | 5,772,616 | 314,584 | SH | SOLE | 314,584 | 0 | 0 | |||
Cytokinetics Inc | EQUITIES | 23282W605 | 801,850 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | |||
Design Therapeutics Inc | EQUITIES | 25056L103 | 585,077 | 57,025 | SH | SOLE | 57,025 | 0 | 0 | |||
Eliem Therapeutics Inc | EQUITIES | 28658R106 | 1,501,771 | 409,202 | SH | SOLE | 409,202 | 0 | 0 | |||
Eloxx Pharmaceuticals Inc | EQUITIES | 29014R202 | 48,914 | 26,876 | SH | SOLE | 26,876 | 0 | 0 | |||
Evogene Ltd | EQUITIES | M4119S104 | 105,253 | 150,361 | SH | SOLE | 150,361 | 0 | 0 | |||
Fresh Tracks Therapeutics Inc | EQUITIES | 10802T204 | 15,000 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
Gilead Sciences Inc | EQUITIES | 375558103 | 4,460,938 | 51,962 | SH | SOLE | 51,962 | 0 | 0 | |||
GlaxoSmithKline PLC | EQUITIES | 37733W204 | 4,785,295 | 136,178 | SH | SOLE | 136,178 | 0 | 0 | |||
Gossamer Bio Inc | EQUITIES | 38341P102 | 217,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
Horizon Therapeutics Plc | EQUITIES | G46188101 | 2,623,545 | 23,054 | SH | SOLE | 23,054 | 0 | 0 | |||
IVERIC bio Inc | EQUITIES | 46583P102 | 1,889,283 | 88,243 | SH | SOLE | 88,243 | 0 | 0 | |||
Immatics Nv | EQUITIES | N44445109 | 3,830,553 | 439,788 | SH | SOLE | 439,788 | 0 | 0 | |||
Immunic Inc | EQUITIES | 4525EP101 | 490,918 | 350,656 | SH | SOLE | 350,656 | 0 | 0 | |||
ImmunoGen Inc | EQUITIES | 45253H101 | 2,020,054 | 407,269 | SH | SOLE | 407,269 | 0 | 0 | |||
ImmunoGen, Inc. | LONG OPTION CALLS | 45253H101 | 1,150,720 | 232,000 | SH | Call | SOLE | 232,000 | 0 | 0 | ||
Immunovant Inc | EQUITIES | 45258J102 | 9,223,149 | 519,614 | SH | SOLE | 519,614 | 0 | 0 | |||
Insmed Inc | EQUITIES | 457669307 | 2,486,811 | 124,465 | SH | SOLE | 124,465 | 0 | 0 | |||
Intellia Therapeutics Inc | EQUITIES | 45826J105 | 1,143,345 | 32,770 | SH | SOLE | 32,770 | 0 | 0 | |||
Intra-Cellular Therapies Inc | EQUITIES | 46116X101 | 7,428,169 | 140,366 | SH | SOLE | 140,366 | 0 | 0 | |||
Krystal Biotech Inc | EQUITIES | 501147102 | 4,637,143 | 58,535 | SH | SOLE | 58,535 | 0 | 0 | |||
LAVA Therapeutics NV | EQUITIES | N51517105 | 1,532,167 | 437,762 | SH | SOLE | 437,762 | 0 | 0 | |||
MacroGenics Inc | EQUITIES | 556099109 | 4,109,707 | 612,475 | SH | SOLE | 612,475 | 0 | 0 | |||
Madrigal Parmaceuticals, Inc. | LONG OPTION PUTS | 558868105 | 8,707,500 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | ||
Madrigal Pharmaceuticals Inc | EQUITIES | 558868105 | 14,482,895 | 49,898 | SH | SOLE | 49,898 | 0 | 0 | |||
Medicus Sciences Acquisition Corp | WARRANTS | G5960S124 | 4,499 | 49,990 | SH | SOLE | 49,990 | 0 | 0 | |||
Meiragtx Holdings Plc | EQUITIES | G59665102 | 369,501 | 56,672 | SH | SOLE | 56,672 | 0 | 0 | |||
Mersana Therapeutics Inc | EQUITIES | 59045L106 | 6,681,467 | 1,140,182 | SH | SOLE | 1,140,182 | 0 | 0 | |||
Merus NV | EQUITIES | N5749R100 | 4,249,671 | 274,704 | SH | SOLE | 274,704 | 0 | 0 | |||
Morphic Holding Inc | EQUITIES | 61775R105 | 8,948,811 | 334,535 | SH | SOLE | 334,535 | 0 | 0 | |||
Nuvalent Inc | EQUITIES | 670703107 | 9,022,238 | 302,963 | SH | SOLE | 302,963 | 0 | 0 | |||
Oric Pharmaceuticals Inc | EQUITIES | 68622P109 | 7,281,783 | 1,236,296 | SH | SOLE | 1,236,296 | 0 | 0 | |||
Pharvaris NV | EQUITIES | N69605108 | 1,125,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
Phreesia Inc | EQUITIES | 71944F106 | 2,763,220 | 85,390 | SH | SOLE | 85,390 | 0 | 0 | |||
Pliant Therapeutics Inc | EQUITIES | 729139105 | 4,204,333 | 217,503 | SH | SOLE | 217,503 | 0 | 0 | |||
Point Biopharma Global Inc | EQUITIES | 730541109 | 2,921,919 | 400,812 | SH | SOLE | 400,812 | 0 | 0 | |||
Poseida Therapeutics Inc | EQUITIES | 73730P108 | 11,819,000 | 2,230,000 | SH | SOLE | 2,230,000 | 0 | 0 | |||
Praxis Precision Medicines Inc | EQUITIES | 74006W108 | 234,213 | 98,409 | SH | SOLE | 98,409 | 0 | 0 | |||
Prometheus Bioscience, Inc. | LONG OPTION PUTS | 74349U108 | 18,964,000 | 172,400 | SH | Put | SOLE | 172,400 | 0 | 0 | ||
Prometheus Biosciences Inc | EQUITIES | 74349U108 | 5,500,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
Prothena Corporation PLC | EQUITIES | G72800108 | 4,320,287 | 71,706 | SH | SOLE | 71,706 | 0 | 0 | |||
Schrodinger Inc | EQUITIES | 80810D103 | 2,018,520 | 108,000 | SH | SOLE | 108,000 | 0 | 0 | |||
Seagen Inc | EQUITIES | 81181C104 | 1,415,666 | 11,016 | SH | SOLE | 11,016 | 0 | 0 | |||
Seres Therapeutics Inc | EQUITIES | 81750R102 | 2,096,763 | 374,422 | SH | SOLE | 374,422 | 0 | 0 | |||
Stereotaxis Inc | EQUITIES | 85916J409 | 734,695 | 354,925 | SH | SOLE | 354,925 | 0 | 0 | |||
Terns Pharmaceuticals Inc | EQUITIES | 880881107 | 7,126,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
Trevi Therapeutics Inc | EQUITIES | 89532M101 | 1,481,528 | 767,631 | SH | SOLE | 767,631 | 0 | 0 | |||
Uniqure NV | EQUITIES | N90064101 | 226,700 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
United Therapeutics Corp | EQUITIES | 91307C102 | 4,462,788 | 16,048 | SH | SOLE | 16,048 | 0 | 0 | |||
Vaxcyte Inc | EQUITIES | 92243G108 | 3,986,323 | 83,135 | SH | SOLE | 83,135 | 0 | 0 | |||
Veracyte Inc | EQUITIES | 92337F107 | 4,746,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
Vertex Pharmaceuticals Inc | EQUITIES | 92532F100 | 3,287,472 | 11,384 | SH | SOLE | 11,384 | 0 | 0 | |||
Veru Inc. | LONG OPTION PUTS | 92536C103 | 924,000 | 175,000 | SH | Put | SOLE | 175,000 | 0 | 0 | ||
Viewray Inc | EQUITIES | 92672L107 | 10,776,013 | 2,405,360 | SH | SOLE | 2,405,360 | 0 | 0 | |||
Viridian Therapeutics Inc | EQUITIES | 92790C104 | 87,630 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | |||
WAVE Life Sciences Ltd | EQUITIES | Y95308105 | 350,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
Xenon Pharmaceuticals Inc | EQUITIES | 98420N105 | 10,001,617 | 253,655 | SH | SOLE | 253,655 | 0 | 0 |